Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
Reference is made to the announcement jointly issued by the Offeror and the Company dated 18 December 2015 in relation to, among other things, close of the Offers, results of the Offers and public float (the "Closing Announcement") and the announcement of the Company dated 21 December 2015 in relation to the suspension of trading in Shares (the "Trading Suspension Announcement"). Capitalised terms used in this announcement shall have the same meanings as defined in the Closing Announcement unless otherwise defined.
As disclosed in the Closing Announcement and Trading Suspension Announcement, immediately following the close of the Offers, taking into account the valid acceptances in respect of 554,666,559 Offer Shares, the Offeror and parties acting in concert with it became interested in an aggregate of 1,868,696,559 Shares, representing approximately 93.33% of the entire issued share capital of the Company. As a result, the public float of the Company has fallen to approximately 6.67% which is below the minimum public float requirement under Rule 8.08(1)(a) of the Listing Rules.
The Company had applied to the Stock Exchange for a temporary waiver from strict compliance with Rules 8.08(1)(a) and 13.32(1) of the Listing Rules (the "Waiver") for a period of three months from 18 December 2015 to 18 March 2016 (the "Waiver Period"). On 12 January 2016, the Stock Exchange granted the Waiver to the Company for the Waiver Period. Further announcement(s) will be made by the Company regarding the restoration of public float as and when appropriate pursuant to the Listing Rules.
By order of the Board
Natural Beauty Bio-Technology Limited Tsai Yen-YuChairperson
Hong Kong, 15 January 2016
As at the date of this announcement, the Board comprises Dr. Tsai Yen-Yu, Mr. Lee Ming-Ta and Dr. Su Chien-Cheng as executive directors; Dr. Su Sh-Hsyu, as non-executive director; and Mr. Chen Ruey-Long, Mr. Yang Tze-Kaing and Mr. Lu Chi-Chant as independent non-executive directors.
Natural Beauty Bio-Technology Ltd. issued this content on 2016-01-15 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-15 10:22:10 UTC
Original Document: http://www.corpasia.net/hongkong/00157/announce/300/EN/e_00157ann-20160115_ermJ3UbB3Ae6.pdf
